SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-097768
Filing Date
2024-04-16
Accepted
2024-04-16 16:16:58
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFA14A d791576ddefa14a.htm DEFA14A 29276
2 GRAPHIC g791576dsp001.jpg GRAPHIC 206033
3 GRAPHIC g791576dsp003.jpg GRAPHIC 215960
4 GRAPHIC g791576dsp004.jpg GRAPHIC 332832
5 GRAPHIC g791576dsp006.jpg GRAPHIC 322118
6 GRAPHIC g791576g0412022450900.jpg GRAPHIC 3838
  Complete submission text file 0001193125-24-097768.txt   1519757
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-16174 | Film No.: 24848030
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)